Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Gross Margin (2020 - 2025)

RxSight (RXST) has disclosed Gross Margin for 6 consecutive years, with 77.47% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 589.0% year-over-year to 77.47%, compared with a TTM value of 76.6% through Dec 2025, up 589.0%, and an annual FY2025 reading of 76.6%, up 589.0% over the prior year.
  • Gross Margin was 77.47% for Q4 2025 at RxSight, down from 79.86% in the prior quarter.
  • Across five years, Gross Margin topped out at 79.86% in Q3 2025 and bottomed at 16.58% in Q2 2021.
  • Average Gross Margin over 5 years is 53.79%, with a median of 60.52% recorded in 2023.
  • The sharpest move saw Gross Margin skyrocketed 31116bps in 2021, then soared 467bps in 2025.
  • Year by year, Gross Margin stood at 34.05% in 2021, then surged by 35bps to 46.13% in 2022, then soared by 34bps to 61.77% in 2023, then rose by 16bps to 71.59% in 2024, then grew by 8bps to 77.47% in 2025.
  • Business Quant data shows Gross Margin for RXST at 77.47% in Q4 2025, 79.86% in Q3 2025, and 74.88% in Q2 2025.